Agilent Technologies will collaborate with Dr Shane Snyder ? an internationally recognized authority on water contamination from the University of Arizona?s Department of Chemical and Environmental Engineering ? and the university?s BIO5 Institute to develop new methods of detecting emerging contaminants in water, according to a company press release.
Agilent Technologies will collaborate with Dr Shane Snyder — an internationally recognized authority on water contamination from the University of Arizona’s Department of Chemical and Environmental Engineering — and the university’s BIO5 Institute to develop new methods of detecting emerging contaminants in water, according to a company press release.
Emerging contaminants can include pharmaceuticals, personal care products and other commonly used substances. The collaboration aims to increase the ability to accurately detect contamination in water supplies.
Dr Snyder commented that the partnership with Agilent will allow the University of Arizona to more effectively influence water reuse and desalination strategies by ensuring that the required water quality has been achieved for its intended use.
“Not only will we investigate known potential threats to water quality, we will also bridge the gap between detection and health by developing methodologies that can screen water for toxicity from multiple compounds,” he said.
The concept of addressing contaminants in potable water as mixtures — instead of separate chemicals— is of great interest to the regulatory, scientific and public communities.
The collaboration will be centered at the BIO5 Institute on the University of Arizona campus, where the infrastructure for cross-disciplinary work combining biological and chemical research already exists.
The BIO5 Institute at the University of Arizona mobilizes top researchers in five disciplines — agriculture, engineering, medicine, pharmacy and basic science — to find solutions to important health and environmental problems.
For more information, visit www.engineering.arizona.edu, www.bio5.org or www.agilent.com
This story originally appeared in The Column. Click here to view that issue.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.